By Anosha Khan ( February 24, 2026, 3:50 PM EST) -- The Federal Court has denied the certification of a proposed class action seeking $5 billion in damages against pharmaceutical companies for allegedly conspiring to fix drug prices in Canada and the U.S. on an industry-wide basis....